Story · Medicine & Biotech

Effect of Saroglitazar in MASLD: Latest Indian 2026 Study

1 outlet · first reported by Medical Dialogues on

Saroglitazar was associated with improvements in liver stiffness, hepatic steatosis, metabolic parameters and non-invasive fibrosis markers in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a recent Indian study. This study was published in the February… (Medical Dialogues)

Coverage, in order

  1. Medical Dialogues India obscure study observationalpeer-reviewed
    Effect of Saroglitazar in MASLD: Latest Indian 2026 Study

    Saroglitazar was associated with improvements in liver stiffness, hepatic steatosis, metabolic parameters and non-invasive fibrosis markers in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a recent Indian study. This study was published in the February…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.